Cyclophosphamide for anticancer therapy-induced interstitial lung disease in the modern era: a retrospective cohort study

Cyclophosphamide for anticancer therapy-induced interstitial lung disease in the modern era: a retrospective cohort study

BackgroundDrug-induced interstitial lung disease (DIILD) is a serious complication of cancer treatment that is primarily treated with corticosteroids. However, effective standardized regimens for corticosteroid-refractory DIILD have not been established. Cyclophosphamide (CPA) is an immunosuppressan...

Full description

Saved in:
Bibliographic Details
Main Authors: Honami Katahara, Kaede Baba, Hiromichi Nakajima, Chikako Funasaka, Chihiro Kondoh, Yoichi Naito, Hibiki Udagawa, Kohei Shitara, Tomoaki Sasaki, Toshikatsu Kawasaki, Toru Mukohara
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Oncology
Subjects:
drug-induced interstitial lung disease
cyclophosphamide
corticosteroid-refractory
immune-related pneumonitis
immunosuppressant
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1567317/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1567317/full

Similar Items